MET Gene

What the MET Gene Means in Everyday Medical Language

The MET gene is a part of our DNA that tells cells how to make a protein important for cell growth and survival. This protein acts like a signal that helps cells grow, divide, and repair themselves. Sometimes, changes or mutations in the MET gene can cause this signaling to go wrong, leading to uncontrolled cell growth, which can contribute to cancer.

Mutations in the MET gene have been found in several types of cancer, including some lung cancers and a rare inherited kidney cancer called hereditary papillary renal cancer (HPRC). In these cases, the MET gene mutation helps cancer cells grow and spread more easily.

Why the MET Gene Can Matter in Cancer Care

Knowing whether a cancer has a MET gene mutation can help doctors choose treatments that target this specific problem. For example, capmatinib (brand name Tabrecta) is a medicine designed to block the protein made by the MET gene. By blocking this protein, capmatinib may slow down or stop cancer growth and sometimes kill cancer cells. This drug is approved for adults with a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread and has a MET mutation.

Because not all cancers have MET mutations, genetic testing of the cancer tissue is needed to find out if this treatment might be helpful. This personalized approach aims to give patients treatments that are more likely to work for their specific cancer.

What Patients Might See or Hear About the MET Gene

If your doctor mentions the MET gene, it may be during discussions about genetic testing or treatment options. You might hear about capmatinib or Tabrecta as a possible medicine if your cancer has this mutation. You may also see the term MET gene in medical reports, genetic test results, or educational materials about your cancer.

It’s important to remember that hearing about the MET gene or related drugs does not mean a diagnosis or treatment plan is set in stone. Instead, it is a piece of information that helps your care team decide the best approach for you.

Where the Term MET Gene Might Appear

The MET gene may be mentioned in your pathology or genetic testing reports, treatment plans, or during visits with your healthcare team. It can also appear in drug information sheets, clinical trial descriptions, or educational materials about lung or kidney cancers.

What the MET Gene Does Not Automatically Mean

Finding a MET gene mutation does not mean cancer is cured or that a specific treatment will definitely work. It also does not mean everyone with cancer has this mutation—only a small number of cancers have changes in the MET gene. Additionally, while drugs like capmatinib target MET mutations, they are approved only for certain cancers and situations.

Also, the presence of a MET mutation is found through genetic testing of the cancer tissue, not by symptoms or general diagnosis alone. It’s important not to overinterpret the term without discussing it with your care team.

Practical Questions to Ask Your Care Team

If the MET gene or related treatments come up, you might ask: Does my cancer have a MET mutation? Is capmatinib or another targeted therapy an option for me? What are the possible benefits and side effects? How will treatment be given and monitored? Are there clinical trials involving MET-targeted treatments that I could consider?

How to Read the Term MET Gene in Context

The MET gene is one part of a complex picture that your healthcare team uses to understand and treat cancer. It’s best to ask your care providers how this term applies to your specific test results, treatment plan, or symptoms. This helps you make informed decisions based on your unique situation.

Safety and Next Steps

This information is meant to help you understand what the MET gene is and why it might be important in cancer care. It does not replace medical advice or decisions made by your healthcare team. If you see the term MET gene in your records or hear it during your care, the safest next step is to ask your doctors or nurses what it means for you personally. They can explain how it fits into your diagnosis, treatment options, and follow-up care.